Ando, Tomo http://orcid.org/0000-0001-6827-8234
Yamaji, Kyohei
Kohsaka, Shun
Fukutomi, Motoki
Onishi, Takayuki
Inohara, Taku
Ishii, Hideki
Amano, Tetsuya
Ikari, Yuji
Tobaru, Tetsuya
Article History
Received: 20 October 2022
Accepted: 17 April 2023
First Online: 25 April 2023
Declarations
:
: K.Y. reports investigator-initiated grant funding from Abbott. H.I. received lecture fees from Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Mochida Pharma, Novartis Pharma, and Otsuka Pharma. T.A. receives lecture fees from Astellas Pharma, AstraZeneca, Bayer, Daiichi Sankyo, and Bristol-Myers Squibb. The rest of the authors have no conflict of interest to report. S.K. has received an unrestricted research grant from the Department of Cardiology, Keio University School of Medicine, Bayer Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Novartis Pharmaceutical Co., Ltd. All other authors have no related disclosures.